Table 1– Elastographic and histological data
PatientLymph node areasSize mm/PET SUVHistogram analysisTBNA histologyFinal case diagnosis
Mean deformation#Hard areas %
14R16/10.45571Lymph node tissue, no malignant cellsTTF1- adenocarcinoma
4L14/3.71098TTF1- adenocarcinoma
24R17/34981TTF1+ adenocarcinomaTTF1+ adenocarcinoma
32R13/2.11676Lymph node tissue, no malignant cellsLymph nodes considered to be malignant on PET and CT, and a history of adenocarcinoma
4R13/2.96764Lymph node tissue, no malignant cells
44R16,3/6.21269Lymph node tissue, no malignant cells dystrophic epithelial cellsLarge cell carcinoma on bronchial aspiration (right lower lobe mass)
510R10/NA1611No lymphocytes, no malignant cellsTuberculosis (clinical and radiological appearance and CT response to trial therapy)
64R16/NA14418Lymph node tissue, no malignant cellsSarcoma (transthoracic biopsy of a right lower lobe mass)
721/NA1425Lymph node tissue, no malignant cells
74R21/10.42687TTF1+ adenocarcinomaTTF1+ adenocarcinoma
811R20.8/5.66171Lymph node tissue, no malignant cellsEBV-induced lymphoma (biopsy of parotid and cerebral lesions)
94R29/116100TTF1+ adenocarcinomaTTF1+ adenocarcinoma
104R30/116100TTF1+ adenocarcinomaTTF1+ adenocarcinoma
  • PET: positron emission tomography; SUV: standardised uptake value; TBNA: transbronchial needle aspiration; TTF: thyroid transcription factor; CT: computed tomography; EBV: Epstein–Barr virus; NA: data not available. #: from 0 to 255.